It doesn't matter if you like it or not, Jaguar is doing something nobody else ever could, because that's exactly what Jag ...

Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines ...

Should Jaguar expand its newly-designed electric vehicle portfolio with a true all-quiet land yacht similar to this rendered ...

This ongoing proof-of-concept study is evaluating ... Hepatology & Nutrition Division. Jaguar is supporting multiple clinical investigations, including additional IITs, for crofelemer together ...

"I look forward to presenting preliminary, proof-of-concept results from this study at the ELITE PED-GI Congress." This ongoing proof-of-concept study is evaluating crofelemer's potential to be ...

Introduced in 2003, the third generation of XJ was the first to leverage the parts bin of its then-parent, the Ford Motor Company.

However, the Jaguar brand has been at the forefront of innovative design and styling that pushes boundaries for a lot longer ...

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress ACCESS Newswire Apr 17, 2025 ...

Jaguar Health’s Napo Pharmaceuticals and Napo Therapeutics announced that preliminary results from the ongoing pediatric investigator-initiated trial of a novel liquid formulati ...